MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Obesity, unspecified (E66.9)

HealthDay 12 July at 03.25 PM

Parents' Weight Status at Age 17 Correlates to Offspring Weight at 17

The weight status of parents at 17 years of age is associated with obesity risk for both female and male offspring, according to a study published online June 28 in JAMA Network Open.Gabriel Chodick, Ph.D., from Tel Aviv University in Israel, and colleagues assessed the heritability of obesity. The analysis included 447,883 offspri

HealthDay 09 July at 03.42 PM

Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.Ildiko Lingvay, M.D., from the University of Texas Southwestern Medical Center in Da

HealthDay 03 July at 08.32 PM

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and

HealthDay 01 July at 10.10 PM

Small Differences in Weight Change With First-Line Antidepressants

For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted

HealthDay 01 July at 05.50 PM

American Diabetes Association, June 21-24

The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances in di

HealthDay 28 June at 03.03 PM

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among patients with moderate-to-severe obstructive sleep apnea (OSA) and obesity, according to a study published online June 21 in the Journal of the American College of Cardiology.Ali Aminian,

HealthDay 27 June at 03.18 PM

Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD

For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm

HealthDay 26 June at 03.26 PM

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At

HealthDay 25 June at 03.03 PM

Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder

Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa

HealthDay 25 June at 03.01 PM

Intermittent Fasting Aids Early Diabetes Outcomes More Than Drugs

Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti

HealthDay 20 June at 08.50 PM

Timing of Exercise Significant for Obesity, Metabolic Impairment

For sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical activity (MVPA) is significant, with a beneficial effect on glucose homeostasis for accumulation of more MVPA in the evening, according to a study published online June 10 in Obesity.Antonio Clavero-Jimeno, from the Univ

HealthDay 18 June at 03.46 PM

Multimodal Antiobesity Medications Yield Superior Preoperative Weight Loss

Combining antiobesity medications enhances preoperative weight loss in individuals with high body mass index (BMI) preparing for metabolic surgery, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.Michael Kachmar, D.O., from the Pennington Biome

HealthDay 18 June at 03.37 PM

Less Than One-Quarter of Patients Hospitalized for CVD Receive Dietary Counseling

Dietary counseling is infrequently documented after hospitalization for cardiovascular disease (CVD) episodes, according to a study recently published in the Journal of the Academy of Nutrition and Dietetics.Eric J. Brandt, M.D., from the University of Michigan in Ann Arbor, and colleagues used data from the Michigan Value Collabo

HealthDay 17 June at 10.51 PM

Meal Replacement + Financial Incentives Beneficial for Teens With Obesity

For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater reduction in body mass index (BMI) and total body fat mass than MRT alone, according to a study published online June 17 in JAMA Pediatrics.Amy C. Gross, Ph.D., from the University of Minnesota Center for Pediatric Obesity

HealthDay 14 June at 03.33 PM

Midlife Inflammation Tied to Slowing of Gait Speed in Later Life

Inflammation in midlife may contribute to clinically meaningful late-life slowing of gait speed, according to a study published online June 12 in the Journal of the American Geriatrics Society.Kirby G. Parker, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues examined the relationship between midlif

HealthDay 13 June at 04.10 PM

GLP-1 RA Use Linked to Lower Quality of Bowel Preparation

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R

Evalytics 06 May at 07.12 PM

Report finds Nestlé adds sugars to baby food in low-income countries

The report reveals Nestlé adds sugars to baby food in low-income countries. Nestlé is accused of marketing unhealthy products to vulnerable populations. Experts raise concerns about the impact on infant health and call for stricter regulations.

Evalytics 19 March at 06.36 AM

The growing threat of fungal infections

Two converging crises are exacerbating the challenges posed by fungal infections, according to experts. First, as humans live longer but grapple with a higher prevalence of health conditions like obesity, diabetes, and inflammatory diseases, our susceptibility to fungal infections increases. These conditions create an environment where fungi can thrive, finding hospitable hosts in our bodies.

Evalytics 19 March at 06.08 AM

FDA approves first drug for common form of liver inflammation

The FDA has approved the first-ever medication for nonalcoholic steatohepatitis (NASH), a common form of liver inflammation linked to obesity, type 2 diabetes, and other metabolic conditions. NASH, characterized by liver inflammation due to excess fat accumulation, affects an estimated 6 to 8 million people in the US with moderate to advanced fibrosis.

Evalytics 11 March at 01.08 AM

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

"Wegovy," an obesity drug, is approved for reducing heart attack and stroke risk. It's a higher-dose version of a diabetes medicine that aids weight loss. The drug's approval signals a new option for tackling obesity-related health risks.

Evalytics 05 March at 06.03 AM

Metformin's Potential Beyond Diabetes: Exploring Diverse Health Benefits

Metformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp

Evalytics 04 March at 06.12 PM

Eating Smart in a Processed World: The Truth About Ultra-Processed Foods

The BMJ study by Lane MM et al. warns of health risks from ultra-processed foods like obesity and heart disease due to their poor nutrition. Global trends call for stricter regulations and healthier options. Both individuals and the food industry must act to promote healthier eating habits.

Evalytics 13 February at 06.34 PM

Weight-loss drugs aren't a magic bullet. Lifestyle changes are key to lasting health

The article stresses that weight-loss drugs such as Ozempic are not a quick fix, advocating for lifestyle changes alongside medication for sustained health benefits. It underlines the need for a holistic approach beyond medication, emphasizing long-term healthy habits for effective weight management.

Evalytics 05 February at 08.38 PM

Global cancer cases will jump 77% by 2050, WHO report estimates

The WHO projects global cancer cases to reach 35 million by 2050, driven by lifestyle and environmental factors. The report underscores significant regional disparities in cancer care and an increasing trend of younger people being affected.

HealthDay 31 January at 04.57 PM

Cardio, Cardio + Resistance Training Improve CVD Risk Profile at One Year

In adults with overweight or obesity, aerobic exercise alone or a combined resistance plus aerobic exercise program leads to improvements in composite cardiovascular disease (CVD) risk profiles at one year, according to a study published online Jan. 17 in the European Heart Journal.Duck-chul Lee, Ph.D., from Iowa State Universit

HealthDay 30 January at 04.20 PM

Diabetes Risk in Overweight, Obese Teens Varies Substantially by Baseline HbA1c

Five-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a study published online Jan. 17 in JAMA Network Open.Francis M. Hoe, M.D., from Kaiser Permanente Roseville Medical Center in California, and colleagues assessed the risk for future type 2 diabetes (T2D) amon

Evalytics 29 January at 05.35 PM

The fountain of youth is ... a T cell?

Scientists reprogrammed T cells to remove aging-related senescent cells in mice, enhancing health and longevity. This single treatment approach holds potential for addressing age-related conditions, moving us closer to a "fountain of youth."

Evalytics 29 January at 05.35 PM

The fountain of youth is ... a T cell?

Scientists reprogrammed T cells to remove aging-related senescent cells in mice, enhancing health and longevity. This single treatment approach holds potential for addressing age-related conditions, moving us closer to a "fountain of youth."

Evalytics 29 January at 05.35 PM

The fountain of youth is ... a T cell?

Scientists reprogrammed T cells to remove aging-related senescent cells in mice, enhancing health and longevity. This single treatment approach holds potential for addressing age-related conditions, moving us closer to a "fountain of youth."

HealthDay 24 January at 04.46 PM

Cutting Social Isolation, Loneliness May Lower Mortality in People With Obesity

Improving social isolation and loneliness may attenuate excess obesity-related mortality risk, according to a study published online Jan. 22 in JAMA Network Open.Jian Zhou, M.D., from the Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues investigated whether improvement of social isol

HealthDay 23 January at 04.59 PM

2009 Update to WIC Cost-Effective for Reducing Childhood Obesity

The 2009 update to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) was estimated to be cost-effective for preventing childhood obesity, according to a study published online Jan. 23 in Pediatrics.Erica L. Kenney, Sc.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and colleague

Evalytics 22 January at 03.05 PM

Dr. Sanjay Gupta: What weight tells us about our health

The CNN article examines changing views on body weight, discussing obesity's classification as a disease and the rise of effective weight loss medications. It addresses the societal and medical implications, including weight-related stigma and the limitations of BMI, while exploring new perspectives on obesity and health.

HealthDay 20 January at 12.16 AM

High Stress From Teenage Years to Adulthood May Up Cardiometabolic Risk

Consistently high perceived stress from adolescence to adulthood is associated with increased cardiometabolic risk in adulthood, according to a study published online Jan. 17 in the Journal of the American Heart Association.Fangqi Guo, Ph.D., from the Keck School of Medicine at the University of Southern California in Los Angeles, and c

HealthDay 19 January at 11.59 PM

Breastfeeding Linked to Lower Child BMI for Age Z-Score

Regardless of maternal body mass index (BMI) category, breastfeeding is associated with a lower child BMI for age z-score (BMIz), according to a study published online Dec. 19 in Pediatrics.Gayle M. Shipp, Ph.D., R.D.N., from Michigan State University in Flint, and colleagues analyzed 8,134 dyads from 21 cohorts in the Environmental Inf

HealthDay 19 January at 05.00 PM

Risk Factors ID'd for Monoclonal Gammopathy of Undetermined Significance

For individuals at increased risk for multiple myeloma, risk factors associated with mass spectrometry (MS) monoclonal gammopathy of undetermined significance (MGUS) include obesity, heavy smoking, and short sleep duration, according to a study published online Jan. 11 in Blood Advances.David J. Lee, M.D., from Massachusetts General Hos

HealthDay 17 January at 04.28 PM

Bariatric Surgery Tied to Slower Cognitive Decline in People With Obesity

Bariatric surgery may slow cognitive decline for people with obesity, according to a study published online Dec. 5 in the Journal of Nutrition, Health & Aging.Evan L. Reynolds, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the effect of surgical weight loss on cognition in individuals with clas

HealthDay 16 January at 04.30 PM

Liraglutide Exerts Weight Loss-Independent, GLP-1R-Dependent Effects

Use of the glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide exerts weight loss-independent, GLP-1R-dependent effects on insulin sensitivity, according to a study published online Oct. 24 in Diabetes.Mona Mashayekhi, M.D., Ph.D., from Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues examined whet

HealthDay 12 January at 11.55 PM

FDA Finds No Evidence Linking Wegovy, Ozempic to Suicidal Behaviors

In a preliminary review, the U.S. Food and Drug Administration says it has found no evidence drugs like Wegovy and Ozempic cause suicidal thoughts or actions.Still, the agency noted officials cannot rule out that "a small risk may exist," and it will continue to look into similar reports involving these glucagon-like peptide-1 receptor agonists.

HealthDay 09 January at 05.09 PM

Risk for Suicidal Ideation Not Increased With Semaglutide

For individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like peptide 1 receptor (GLP1R) agonist antiobesity medications, according to a study published online Jan. 5 in Nature Medicine.William Wang, from the Case Western Reserve

Evalytics 08 January at 09.12 PM

Eli Lilly launches website to help patients get weight loss drugs

The linked article discusses how Eli Lilly, a pharmaceutical company, is now offering a weight loss drug online through a website. The drug aims to help people struggling with obesity.

HealthDay 05 January at 10.33 PM

One-Third of Patients Persist on Antiobesity Medications at Six Months

Later-stage persistence with antiobesity medication (AOM) varies based on the drug and six-month weight loss, according to a study published online Dec. 6 in Obesity.Hamlet Gasoyan, Ph.D., M.P.H., from the Cleveland Clinic, and colleagues examined the percentage of patients with an initial AOM fill who were persistent with AOM at th

HealthDay 27 December at 10.15 PM

Quality of Low-Carb Diets Affects Weight Change in U.S. Adults

The quality of low-carbohydrate diets (LCDs) is associated with weight change among U.S. adults, according to a study published online Dec. 27 in JAMA Network Open.Binkai Liu, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a prospective cohort study to examine associations between changes in LC

HealthDay 26 December at 05.07 PM

Beans Beneficial for Patients With History of Colorectal Neoplasia

Adding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study published in the December issue of eBioMedicine.Xiaotao Zhang, M.D., Ph.D., from The University of Texas MD Anderson Cancer Center in Houston, and colleagues conduc

Evalytics 22 December at 03.23 PM

CNN Exclusive: Older weight loss drugs are making a comeback as Zepbound, Wegovy remain out of reach for many

The article examines the renewed attention on older weight loss drugs like phentermine and orlistat in light of the ongoing obesity crisis, as researchers reevaluate their effectiveness and safety.

HealthDay 20 December at 10.58 PM

Waist Circumference Predicts Infertility in Child-Bearing-Aged Women

Waist circumference (WC) is a positive predictor of female infertility, independent of body mass index (BMI), according to a study published online Dec. 20 in PLOS ONE.Jierong Ke, from Huizhou Central People's Hospital in China, and colleagues examined the relationship between WC and infertility among women of child-bearing age.

HealthDay 20 December at 05.04 PM

Social Determinants of Health Needs More Likely for Patients With ED Encounters

Patients with emergency department encounters are more likely to screen positive for social determinants of health (SDOH) needs, according to a research letter published online Dec. 19 in JAMA Network Open.Stacie Vilendrer, M.D., M.S.P.H., from the Stanford University School of Medicine in California, and colleagues conducted a cross

HealthDay 19 December at 04.39 PM

Inflammatory-Related Perinatal Factors Tied to Later Childhood Dysregulation

Maternal inflammation risk factors during pregnancy may be associated with later dysregulation in children, according to a study published online in the December issue of the Journal of the American Academy of Child & Adolescent Psychiatry.Jean A. Frazier, M.D., from UMass Chan Medical School in Worcester, and colleagues exami

HealthDay 18 December at 04.50 PM

Obesity in Toddlers on the Rise

Although severe obesity prevalence in toddlers declined from 2010 to 2016, more recent increases have been observed, according to a study published online Dec. 18 in Pediatrics.Lixia Zhao, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the prevalence and trends in severe obesity

HealthDay 18 December at 04.28 PM

Patient Factors ID'd That Predict Low or No Postoperative Opioid Use

Younger age, being opioid-naïve, and a lower discharge pain score are associated with low or no postoperative opioid use, according to a study published online in the December issue of Annals of Surgery Open.Anish K. Agarwal, M.D., M.P.H., from the University of Pennsylvania in Philadelphia, and colleagues sought to identify patient-lev

HealthDay 11 December at 11.55 PM

High BMI in Adolescence Linked to Early CKD in Young Adulthood

High body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and e

HealthDay 11 December at 04.32 PM

Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D

For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC) compared with other antidiabetics, including insulin and metformin, according to a research letter published online Dec. 7 in JAMA Oncology.Lindsey Wang, from the Case We

HealthDay 05 December at 04.19 PM

Lower Pregnancy Weight Gain Seen for Women Who Undergo Bariatric Surgery

Women who have undergone bariatric surgery have lower pregnancy weight gain, according to a study published online Dec. 5 in JAMA Network Open.Huiling Xu, M.D., from the Karolinska Institutet in Stockholm, and colleagues compared pregnancy weight gain among women with a history of bariatric surgery versus those without in a nationwide,

HealthDay 28 November at 04.42 PM

Impacts of Gestational Weight Gain Seen 50+ Years Later

Gestational weight gain might have implications that extend beyond the pregnancy window to long-term health, according to a study published in the Nov. 18 issue of The Lancet.Stefanie N. Hinkle, Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues assessed whether gestationa

Evalytics 27 November at 06.25 PM

Ultra-processed foods and higher risk of mouth, throat and esophagus cancers

A study involving over 450,000 adults found that consuming more ultra-processed foods significantly increases the risk of cancers in the mouth, throat, and esophagus. This research suggests that factors beyond obesity, possibly including food additives, contribute to this heightened risk.

Evalytics 27 November at 06.11 PM

Obesity and Cancer: The Alarming Connection

The article from Evalytics Labs reveals a significant link between obesity in late teens and a heightened risk of 17 cancers, emphasizing the importance of early intervention and healthy lifestyles to reduce these risks.

Evalytics 13 November at 07.10 PM

Wegovy and other weight loss drugs shows promise for heart disease

The NBC News article discusses a study showing that Wegovy, a weight-loss drug, lowers heart attack and stroke risk by 20% in obese adults with heart disease. This groundbreaking research, involving over 17,600 participants, marks the first time a weight-loss medication has shown such cardiac benefits, potentially influencing future treatment and insurance coverage for heart disease.

HealthDay 09 November at 04.14 PM

Eating Disorders Linked to Negative Physical Health

Eating disorders are associated with a significant increase in the risk for physical multimorbidity, according to a study recently published online in Eating and Weight Disorders.Lee Smith, from Anglia Ruskin University in the United Kingdom, and colleagues used data from the 2007 Adult Psychiatric Morbidity Survey (7,403 particip

HealthDay 09 November at 04.08 PM

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro.Zepbound works by activating hormone receptors in the body to reduce appetite

HealthDay 07 November at 11.40 PM

American College of Gastroenterology, Oct. 20-25

The annual meeting of the American College of Gastroenterology was held from Oct. 20 to 25 in Vancouver, British Columbia, Canada, and attracted participants from around the world, including gastroenterology and digestive disease specialists and other health care professionals. The conference featured presentations focusing on clinical updates in gastr

HealthDay 07 November at 04.47 PM

Presenting Weight Loss Treatment as Positive Opportunity Is Beneficial

For patients with obesity seeing a general practitioner, presenting weight loss treatment as a positive opportunity is associated with increased uptake of treatment and more weight loss, according to a study published online Nov. 7 in the Annals of Internal Medicine.Charlotte Albury, D.Phil., from the University of Oxford in the United